The IFIA MedInnovation Department Office was established in October 17,2026 with the mission of supporting inventors and enabling them to connect with other member countries to foster innovation, entrepreneurship, and positive impact across scientific, technological, and business fields.

The Medical and Pharmaceutical Innovations Section of IFIA is established to strengthen IFIA’s global mission in promoting scientific and technological advancement in health-related fields. This section focuses on medical technologies, pharmaceutical innovations, biomedical engineering, biotechnology, and emerging health solutions.

Our mission is to create a global platform for inventors, researchers, innovators, startups, and industry leaders who strive to improve human health through creative and impactful inventions.

IFIA Director of IFIA’s Medical and Pharmaceutical Innovations Section

Professor and Head of the Orthopaedic Department, October 6 University.

Message from the Director

Dr. Mahmoud A. Hafez

Director of IFIA’s Medical and Pharmaceutical Innovations Section

“As part of IFIA’s ongoing commitment to advancing innovation worldwide, our section will serve as a vital hub for medical and pharmaceutical technologies. We aim to cultivate a strong global network of experts, inventors, and innovators who are dedicated to improving healthcare outcomes. I am honored to lead this mission and look forward to accelerating impactful advancements in the medical and pharmaceutical fields.”

Mission

• To support the global community of medical and pharmaceutical innovators.

• To facilitate international cooperation in health-related inventions.

• To promote commercialization and real-world application of medical and pharmaceutical technologies.

• To enhance global health through innovative solutions and interdisciplinary collaborations.

Vision

A world where medical and pharmaceutical innovations accelerate progress, save lives, and elevate the standard of healthcare globally

Key Objectives

• Encouraging research and development in medical and pharmaceutical fields.

• Providing a global platform for presenting and showcasing medical innovations.

• Supporting inventors with patent assistance, networking, and international recognition.

• Organizing specialized events, conferences, workshops, and innovation challenges.

• Building strategic partnerships with universities, research institutes, medical organizations, and health-tech companies.

• Promoting ethical practices and high standards in medical innovation.

Areas of Focus

• Medical devices & equipment

• Surgical technologies

• Biomedical engineering

• Pharmaceutical formulations & drug delivery systems

• Biotechnology and genetic innovation

• Digital health & AI-based medical systems

• Rehabilitation technologies

• Diagnostics & laboratory innovations

• Public health innovation solutions

Programs & Activities

• International innovation awards in medical & pharmaceutical fields

• Mentorship programs for young innovators and researchers

• Collaborative research & development networks

• Global conferences, seminars & exhibitions

• Commercialization support and investor connections

• Innovation acceleration programs

• Medical innovation certification & recognition frameworks

The IFIA MedInnovation Department Office was established in October 17,2026 with the mission of supporting inventors and enabling them to connect with other member countries to foster innovation, entrepreneurship, and positive impact across scientific, technological, and business fields.

Under the leadership of Dr. Mahmoud A. Hafez, the department is dedicated to advancing medical and pharmaceutical innovations, empowering inventors, researchers, and health-tech entrepreneurs to develop and promote breakthrough inventions that improve healthcare and contribute to global scientific progress.

IFIA MedInnovation Department for Advancing Medical and Pharmaceutical Innovation and Development

Definition

1. This Department is an official working body within IFIA. It consists of IFIA members who declare their participation in activities related to medical and pharmaceutical innovations.

2. The Department operates as an integral part of IFIA, under the direct authority of the President, and the oversight of the Executive Committee (ExCo).

3. The Department will therefore:
   a) implement activities decided by the General Assembly (GA) or the ExCo.
   b) act under the general or specific instructions of the President.
   c) suggest new medical and pharmaceutical innovation–related activities to the President.
   d) report directly to the President.

Scope

4. The geographic scope of the Department includes all IFIA member countries, ensuring global collaboration in medical and pharmaceutical innovation.

Functions and Activities

5. The main responsibilities and activities of the Department are to:
   a) develop and strengthen relations between IFIA member associations active in medical and pharmaceutical fields.
   b) establish and maintain useful and regular contacts with patent offices related to medical and pharmaceutical inventions.
   c) build and maintain relations with scientific, technological, medical, pharmaceutical, regulatory, and innovation authorities worldwide.
   d) promote research, development, and commercialization of medical and pharmaceutical innovations.
   e) support inventors, researchers, and health-tech entrepreneurs through programs, events, and international collaboration.

Finances

6. No additional fees will be required from its members.

7. The expenses of the Department will be covered jointly by the IFIA Budget and, when applicable, by contributions from Department members or relevant projects.

Policy

8. The Department must remain a neutral and impartial body, consistent with IFIA’s principles. This means the Department will:
   a) not advance the interests of any specific country or group of countries,
   b) implement the policies decided by the IFIA GA or ExCo,
   c) promote equal opportunities for all inventors and participants in medical and pharmaceutical innovation.

Leadership

9. The Director of the Department, currently Dr. Mahmoud A. Hafez, leads, organizes, and represents the Department and its activities. Additional coordinators or committees may be appointed to assist the Director in fulfilling the objectives and programs of the Department.